|Articles|October 27, 2014

Study Says Prompt Isolation of Symptomatic Patients is Key to Eliminating Ebola

Isolating the sickest Ebola-infected individuals before they progress into their late phase of illness can effectively eliminate the Ebola epidemic in Liberia, according to a modeling study being published in Annals of Internal Medicine.

Currently, West Africa is in the midst of the largest and deadliest Ebola epidemic ever recorded. Liberia has been especially hard-hit with more than 3,500 infections and 2,000 deaths in the past three months. Researchers developed a random transmission model to determine how disease progression and case fatality affect transmission and how patient isolation could achieve disease elimination.

They found that the risk for transmitting Ebola depends on the magnitude of viral load in an infected individual and the number of people with which the infected individual interacts. Here, differentiating between survivors and non-survivors is important because survivors tend to achieve peak viral load approximately four days after symptoms develop and then viral load declines. The survivors were found to have a 32 percent probability of infecting at least one other individual during their infection period.

In non-survivors, viral load is 100-fold higher than that of survivors throughout infection and does not decline after peak. Non-survivors also exhibit more severe Ebola-specific symptoms as illness progresses. Non-survivors had a 67 percent probability of transmitting Ebola to at least one other person.

The researchers' model suggests that isolating the most severely ill individuals (the likely non-survivors) within four days of symptom onset could achieve disease elimination in Liberia.

Source: Annals of Internal Medicine

Newsletter

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Subscribe

Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.